25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

WELCURE DRUGS & PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Let's analyze WELCURE DRUGS & PHARMACEUTICALS LTD. together

I guess you are interested in WELCURE DRUGS & PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of WELCURE DRUGS & PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about WELCURE DRUGS & PHARMACEUTICALS LTD.

I send you an email if I find something interesting about WELCURE DRUGS & PHARMACEUTICALS LTD..

1. Quick Overview

1.1. Quick analysis of WELCURE DRUGS & PHARMACEUTICALS LTD. (30 sec.)










1.2. What can you expect buying and holding a share of WELCURE DRUGS & PHARMACEUTICALS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR0.99
Expected worth in 1 year
INR0.47
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
INR-0.52
Return On Investment
-6.4%

For what price can you sell your share?

Current Price per Share
INR8.07
Expected price per share
INR7.69 - INR8.07
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of WELCURE DRUGS & PHARMACEUTICALS LTD. (5 min.)




Live pricePrice per Share (EOD)
INR8.07
Intrinsic Value Per Share
INR-0.71 - INR0.03
Total Value Per Share
INR0.28 - INR1.02

2.2. Growth of WELCURE DRUGS & PHARMACEUTICALS LTD. (5 min.)




Is WELCURE DRUGS & PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$159.5k$180.3k-$20.8k-13.0%

How much money is WELCURE DRUGS & PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money-$20.8k-$6.2k-$14.5k-69.9%
Net Profit Margin0.0%-50.1%--

How much money comes from the company's main activities?

2.3. Financial Health of WELCURE DRUGS & PHARMACEUTICALS LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of WELCURE DRUGS & PHARMACEUTICALS LTD.?

Welcome investor! WELCURE DRUGS & PHARMACEUTICALS LTD.'s management wants to use your money to grow the business. In return you get a share of WELCURE DRUGS & PHARMACEUTICALS LTD..

First you should know what it really means to hold a share of WELCURE DRUGS & PHARMACEUTICALS LTD.. And how you can make/lose money.

Speculation

The Price per Share of WELCURE DRUGS & PHARMACEUTICALS LTD. is INR8.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of WELCURE DRUGS & PHARMACEUTICALS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in WELCURE DRUGS & PHARMACEUTICALS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR0.99. Based on the TTM, the Book Value Change Per Share is INR-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is INR1.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of WELCURE DRUGS & PHARMACEUTICALS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.010.2%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.010.2%0.000.0%0.000.0%
Usd Price Per Share0.05-0.05-0.07-0.05-0.04-
Price to Earnings Ratio-29.76--29.76--143.34-48.87-66.48-
Price-to-Total Gains Ratio-29.76--29.76-5.30-78.50-78.07-
Price to Book Ratio3.88-3.88-4.98-41.66-55.38-
Price-to-Total Gains Ratio-29.76--29.76-5.30-78.50-78.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.096033
Number of shares10413
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10413 shares)-16.0324.15
Gains per Year (10413 shares)-64.1396.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-64-7409787
20-128-1380193184
30-192-2020290281
40-257-2660386378
50-321-3300483475
60-385-3940580572
70-449-4580676669
80-513-5220773766
90-577-5860869863
100-641-6500966960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.04.00.050.0%4.04.00.050.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of WELCURE DRUGS & PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.129-0.1290%1.053-112%0.195-166%0.124-204%
Book Value Per Share--0.9920.9920%1.121-12%0.449+121%0.288+244%
Current Ratio--1.0391.0390%0.431+141%8.287-87%8.087-87%
Debt To Asset Ratio--0.0220.0220%0.009+150%0.108-79%0.123-82%
Debt To Equity Ratio--0.0230.0230%0.009+154%0.170-87%0.172-87%
Dividend Per Share----0%-0%-0%-0%
Eps---0.129-0.1290%-0.039-70%-0.023-82%-0.014-90%
Free Cash Flow Per Share---0.094-0.0940%0.079-219%0.004-2204%0.004-2650%
Free Cash Flow To Equity Per Share---0.094-0.0940%-1.025+986%-0.216+129%-0.134+42%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.026--------
Intrinsic Value_10Y_min---0.715--------
Intrinsic Value_1Y_max--0.004--------
Intrinsic Value_1Y_min---0.019--------
Intrinsic Value_3Y_max--0.011--------
Intrinsic Value_3Y_min---0.102--------
Intrinsic Value_5Y_max--0.017--------
Intrinsic Value_5Y_min---0.236--------
Market Cap--52021585.00052021585.0000%75397518.000-31%53237674.000-2%42360433.500+23%
Net Profit Margin----0%-0.5010%0.005-100%-0.0010%
Operating Margin----0%-0%0.059-100%0.028-100%
Operating Ratio----0%1.288-100%0.754-100%0.592-100%
Pb Ratio8.135+52%3.8813.8810%4.976-22%41.659-91%55.382-93%
Pe Ratio-62.381-110%-29.761-29.7610%-143.341+382%48.874-161%66.478-145%
Price Per Share8.070+52%3.8503.8500%5.580-31%3.940-2%3.135+23%
Price To Free Cash Flow Ratio-85.457-110%-40.769-40.7690%70.545-158%116.646-135%128.501-132%
Price To Total Gains Ratio-62.372-110%-29.756-29.7560%5.301-661%78.499-138%78.073-138%
Quick Ratio----0%0.089-100%6.594-100%7.028-100%
Return On Assets---0.127-0.1270%-0.034-73%0.091-241%0.050-353%
Return On Equity---0.130-0.1300%-0.035-73%0.044-394%0.014-1005%
Total Gains Per Share---0.129-0.1290%1.053-112%0.195-166%0.124-204%
Usd Book Value--159507.600159507.6000%180311.894-12%72168.859+121%46335.223+244%
Usd Book Value Change Per Share---0.002-0.0020%0.013-112%0.002-166%0.001-204%
Usd Book Value Per Share--0.0120.0120%0.013-12%0.005+121%0.003+244%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%0.000-70%0.000-82%0.000-90%
Usd Free Cash Flow---15184.400-15184.4000%12718.565-219%721.792-2204%595.408-2650%
Usd Free Cash Flow Per Share---0.001-0.0010%0.001-219%0.000-2204%0.000-2650%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.012+986%-0.003+129%-0.002+42%
Usd Market Cap--619056.862619056.8620%897230.464-31%633528.321-2%504089.159+23%
Usd Price Per Share0.096+52%0.0460.0460%0.066-31%0.047-2%0.037+23%
Usd Profit---20801.200-20801.2000%-6259.400-70%-3764.041-82%-2171.527-90%
Usd Revenue----0%12495.000-100%10134.040-100%9592.798-100%
Usd Total Gains Per Share---0.002-0.0020%0.013-112%0.002-166%0.001-204%
 EOD+3 -3MRQTTM+0 -0YOY+7 -245Y+12 -2110Y+14 -18

3.3 Fundamental Score

Let's check the fundamental score of WELCURE DRUGS & PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-62.381
Price to Book Ratio (EOD)Between0-18.135
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.039
Debt to Asset Ratio (MRQ)Less than10.022
Debt to Equity Ratio (MRQ)Less than10.023
Return on Equity (MRQ)Greater than0.15-0.130
Return on Assets (MRQ)Greater than0.05-0.127
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of WELCURE DRUGS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.485
Ma 20Greater thanMa 507.842
Ma 50Greater thanMa 1007.729
Ma 100Greater thanMa 2007.339
OpenGreater thanClose8.070
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About WELCURE DRUGS & PHARMACEUTICALS LTD.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit WELCURE DRUGS & PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Net Profit Margin of 0.0% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-50.1%+50.1%
TTM-5Y0.5%-0.5%
5Y0.5%10Y-0.1%+0.5%
4.3.1.2. Return on Assets

Shows how efficient WELCURE DRUGS & PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • -12.7% Return on Assets means that WELCURE DRUGS & PHARMACEUTICALS LTD. generated ₹-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is -12.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-12.7%0.0%
TTM-12.7%YOY-3.4%-9.3%
TTM-12.7%5Y9.1%-21.8%
5Y9.1%10Y5.0%+4.0%
4.3.1.3. Return on Equity

Shows how efficient WELCURE DRUGS & PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • -13.0% Return on Equity means WELCURE DRUGS & PHARMACEUTICALS LTD. generated ₹-0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM-13.0%0.0%
TTM-13.0%YOY-3.5%-9.6%
TTM-13.0%5Y4.4%-17.5%
5Y4.4%10Y1.4%+3.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of WELCURE DRUGS & PHARMACEUTICALS LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient WELCURE DRUGS & PHARMACEUTICALS LTD. is operating .

  • Measures how much profit WELCURE DRUGS & PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.9%-5.9%
5Y5.9%10Y2.8%+3.1%
4.3.2.2. Operating Ratio

Measures how efficient WELCURE DRUGS & PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are ₹0.00 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.288-1.288
TTM-5Y0.754-0.754
5Y0.75410Y0.592+0.161
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of WELCURE DRUGS & PHARMACEUTICALS LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if WELCURE DRUGS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.04 means the company has ₹1.04 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.039. The company is just able to pay all its short-term debts.
  • The TTM is 1.039. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.039TTM1.0390.000
TTM1.039YOY0.431+0.608
TTM1.0395Y8.287-7.248
5Y8.28710Y8.087+0.199
4.4.3.2. Quick Ratio

Measures if WELCURE DRUGS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₹0.00 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.089-0.089
TTM-5Y6.594-6.594
5Y6.59410Y7.028-0.434
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of WELCURE DRUGS & PHARMACEUTICALS LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of WELCURE DRUGS & PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.02 means that WELCURE DRUGS & PHARMACEUTICALS LTD. assets are financed with 2.2% credit (debt) and the remaining percentage (100% - 2.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.022. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.022. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.022TTM0.0220.000
TTM0.022YOY0.009+0.013
TTM0.0225Y0.108-0.086
5Y0.10810Y0.123-0.015
4.5.4.2. Debt to Equity Ratio

Measures if WELCURE DRUGS & PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Debt to Equity ratio of 2.3% means that company has ₹0.02 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.023. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.023. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.023TTM0.0230.000
TTM0.023YOY0.009+0.014
TTM0.0235Y0.170-0.147
5Y0.17010Y0.172-0.003
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings WELCURE DRUGS & PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare WELCURE DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A PE ratio of -29.76 means the investor is paying ₹-29.76 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The EOD is -62.381. Based on the earnings, the company is expensive. -2
  • The MRQ is -29.761. Based on the earnings, the company is expensive. -2
  • The TTM is -29.761. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-62.381MRQ-29.761-32.621
MRQ-29.761TTM-29.7610.000
TTM-29.761YOY-143.341+113.581
TTM-29.7615Y48.874-78.635
5Y48.87410Y66.478-17.604
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The EOD is -85.457. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -40.769. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -40.769. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-85.457MRQ-40.769-44.687
MRQ-40.769TTM-40.7690.000
TTM-40.769YOY70.545-111.314
TTM-40.7695Y116.646-157.415
5Y116.64610Y128.501-11.855
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of WELCURE DRUGS & PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.88 means the investor is paying ₹3.88 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of WELCURE DRUGS & PHARMACEUTICALS LTD.:

  • The EOD is 8.135. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.881. Based on the equity, the company is fair priced.
  • The TTM is 3.881. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD8.135MRQ3.881+4.254
MRQ3.881TTM3.8810.000
TTM3.881YOY4.976-1.095
TTM3.8815Y41.659-37.778
5Y41.65910Y55.382-13.723
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets13,710
Total Liabilities306
Total Stockholder Equity13,404
 As reported
Total Liabilities 306
Total Stockholder Equity+ 13,404
Total Assets = 13,710

Assets

Total Assets13,710
Total Current Assets318
Long-term Assets13,392
Total Current Assets
Cash And Cash Equivalents 216
Other Current Assets 102
Total Current Assets  (as reported)318
Total Current Assets  (calculated)318
+/-0
Long-term Assets
Property Plant Equipment 209
Long-term Assets Other 309
Long-term Assets  (as reported)13,392
Long-term Assets  (calculated)518
+/- 12,874

Liabilities & Shareholders' Equity

Total Current Liabilities306
Long-term Liabilities0
Total Stockholder Equity13,404
Total Current Liabilities
Other Current Liabilities 105
Total Current Liabilities  (as reported)306
Total Current Liabilities  (calculated)105
+/- 201
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)13,404
Total Stockholder Equity (calculated)0
+/- 13,404
Other
Capital Stock134,391
Common Stock Shares Outstanding 13,512
Net Invested Capital 13,404
Net Working Capital 12
Property Plant and Equipment Gross 209



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
428
234
298
246
730
968
15,289
13,710
13,71015,289968730246298234428
   > Total Current Assets 
428
234
298
246
730
660
59
318
31859660730246298234428
       Cash And Cash Equivalents 
236
127
150
53
475
660
12
216
2161266047553150127236
       Net Receivables 
192
107
148
193
0
0
0
0
0000193148107192
   > Long-term Assets 
0
0
0
0
256
308
15,230
13,392
13,39215,2303082560000
       Property Plant Equipment 
0
0
0
0
0
0
568
209
209568000000
       Other Assets 
0
0
0
0
0
308
308
0
030830800000
> Total Liabilities 
36
36
61
103
36
38
136
306
3061363836103613636
   > Total Current Liabilities 
36
36
61
103
36
38
136
306
3061363836103613636
       Other Current Liabilities 
0
0
1
6
0
0
0
105
1050006100
   > Long-term Liabilities 00000000
> Total Stockholder Equity
392
198
237
143
694
930
15,152
13,404
13,40415,152930694143237198392
   Common Stock
121,186
121,186
121,186
121,186
121,186
121,186
134,391
0
0134,391121,186121,186121,186121,186121,186121,186
   Retained Earnings 0-119,238-120,256-120,492-121,043-120,949-120,988-120,794
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 000000-10



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-2,687
Operating Income-2,687-2,687
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense2,6870
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-2,687
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,748-2,687
EBIT - interestExpense = 0
-1,748
-1,748
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-1,748
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,748
Tax Provision-0
Net Income From Continuing Ops-1,748-1,748
Net Income-1,748
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of WELCURE DRUGS & PHARMACEUTICALS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of WELCURE DRUGS & PHARMACEUTICALS LTD.. The general trend of WELCURE DRUGS & PHARMACEUTICALS LTD. is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine WELCURE DRUGS & PHARMACEUTICALS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of WELCURE DRUGS & PHARMACEUTICALS LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8.07 < 8.07 < 8.07.

The bearish price targets are: 7.69 > 7.69 > 7.69.

Tweet this
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current macd is 0.11713693.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the WELCURE DRUGS & PHARMACEUTICALS LTD. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for WELCURE DRUGS & PHARMACEUTICALS LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the WELCURE DRUGS & PHARMACEUTICALS LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current adx is 90.02.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy WELCURE DRUGS & PHARMACEUTICALS LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current sar is 7.93650675.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current rsi is 99.49. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the WELCURE DRUGS & PHARMACEUTICALS LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Stochastic Oscillator ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current cci is 83.33.

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current cmo is 99.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Williams %R ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of WELCURE DRUGS & PHARMACEUTICALS LTD..

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current atr is 0.01753297.

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Average True Range (ATR) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current obv is 188,303.

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of WELCURE DRUGS & PHARMACEUTICALS LTD.. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) ChartWELCURE DRUGS & PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for WELCURE DRUGS & PHARMACEUTICALS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

WELCURE DRUGS & PHARMACEUTICALS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of WELCURE DRUGS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.485
Ma 20Greater thanMa 507.842
Ma 50Greater thanMa 1007.729
Ma 100Greater thanMa 2007.339
OpenGreater thanClose8.070
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of WELCURE DRUGS & PHARMACEUTICALS LTD. with someone you think should read this too:
  • Are you bullish or bearish on WELCURE DRUGS & PHARMACEUTICALS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about WELCURE DRUGS & PHARMACEUTICALS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about WELCURE DRUGS & PHARMACEUTICALS LTD.

I send you an email if I find something interesting about WELCURE DRUGS & PHARMACEUTICALS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about WELCURE DRUGS & PHARMACEUTICALS LTD..

Receive notifications about WELCURE DRUGS & PHARMACEUTICALS LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.